Key facts
- This page summarizes TPG Group Holdings (SBS) Advisors, Inc.'s Form 4 filing for Progyny, Inc. (PGNY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2021, 16:44.
TPG Group Holdings (SBS) Advisors, Inc. - 06 Jul 2021 Form 4 Insider Report for Progyny, Inc. (PGNY)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- PGNY
- Reported as of
- 06 Jul 2021
- Net transaction value
- -$53,956,458
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2021, 16:44:57 UTC
- Prior SEC filing
- 06 Jul 2021
- Next SEC filing
- 11 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael LaGatta, Vice President, TPG Group Holdings (SBS) Advisors, Inc. (4)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
TPG Group Holdings (SBS) Advisors, Inc. filed Form 4 for Progyny, Inc. (PGNY) on 08 Jul 2021.
Change
- Previous filing in this sequence was filed on 06 Jul 2021.
- Current net transaction value: -$53,956,458.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGNY
transaction
Common Stock
Sale
- Transaction value
- $53,956,458
- Shares
- -897,778
- Change %
- -8.2%
- Price
- $60.10
- Shares after
- 10,000,000
- Date
- 06 Jul 2021
- Ownership
- See Explanation of Responses
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
David Bonderman and James G. Coulter are the sole shareholders of TPG Group Holdings (SBS) Advisors, Inc. (together with Messrs. Bonderman and Coulter, the "Reporting Persons"), which is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of TPG Biotechnologies GenPar III Advisors, LLC, which is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. ("TPG Biotech III"), which directly holds 10,000,000 shares of Common Stock, $0.0001 par value per share, of Progyny, Inc.
Footnote F2
Because of the relationship between the Reporting Persons and TPG Biotech III, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG Biotech III. Each of TPG Biotech III and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG Biotech III's or such Reporting Person's pecuniary interest therein, if any.
Footnote F3
Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
SEC remarks
(4) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (5) Gerald Neugebauer is signing on behalf of both Messrs. Bonderman and Coulter pursuant to authorization and designation letters dated February 26, 2020, which were previously filed with the Securities and Exchange Commission.